Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 12/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 12/20 | 0.68 |
| ▸ | MAPT | P10636 | 9/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.68 |
| ▸ | HPGD | P15428 | 8/20 | 0.68 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.59 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 2/20 | 0.51 |
| ▸ | MAOB | P27338 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15458341 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL14425935 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL14425595 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL14425939 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL15458332 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL14425570 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL14425578 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL14425559 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL22186231 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL14426013 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024004963-A1 | ORGANIC ELECTROLUMINESCENT LIGHT-EMITTING ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT LIGHT-EMITTING ELEMENT, ORGANIC EL DISPLAY DEVICE, ORGANIC EL LIGHTING, ORGANIC ELECTROLUMINESCENT LIGHT-EMITTING ELEMENT-FORMING COMPOSITION, AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT LIGHT-EMITTING ELEMENT | 三菱ケミカル株式会社 | 2024-01-04 | — | — | WO | disclosed |
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-01-05 | — | — | US | disclosed |
| WO-2022255427-A1 | AROMATIC COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, COMPOSITION, AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENCE ELEMENT | 三菱ケミカル株式会社 | 2022-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | INF2, EMC2, DRD4 | MEN1 1500/4885KMT2A 3424/4885MAPT 2746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.